ProfileGDS2971 / 6.4.12.19
TitleHemiasterlin analog HTI-286 effect on docetaxel-resistant prostate cancer cell line
OrganismHomo sapiens


HTI-286 docetaxel GSM206100 GSM206166 GSM206167 GSM206168 GSM206169 GSM206170 GSM206357 GSM206358 GSM206359 GSM206360 GSM206361 GSM206362 94% 29% 10% 4% 78% 23% 78% 18% 44% 93% 3% 88% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM206100HTI-286 in docetaxel-refractory prostate cancer (Biological Replicate 1)1.6575994
GSM206166HTI-286 in docetaxel-refractory prostate cancer (Dye Flip 1)-0.24826329
GSM206167HTI-286 in docetaxel-refractory prostate cancer Biological Replicate 2-0.72099110
GSM206168HTI-286 in docetaxel-refractory prostate cancer (Biological Replicate 3)-1.955314
GSM206169HTI-286 in docetaxel-refractory prostate cancer (Dye flip2)0.41989578
GSM206170HTI-286 in docetaxel-refractory prostate cancer (dyeflip3)-0.52383323
GSM206357HTI-286 in docetaxel-refractory prostate cancer_docet (Dye flip1)0.50231178
GSM206358HTI-286 in docetaxel-refractory prostate cancer_docet (Biological Replicate1)-0.79685918
GSM206359HTI-286 in docetaxel-refractory prostate cancer_docet (Dye flip2)-0.033745944
GSM206360HTI-286 in docetaxel-refractory prostate cancer_docet (Biological Replicate2)1.5602493
GSM206361HTI-286 in docetaxel-refractory prostate cancer_docet (Dye flip3)-2.393123
GSM206362HTI-286 in docetaxel-refractory prostate cancer_docet (Biological Replicate3)1.2838288